Sweden
· Delayed Price · Currency is SEK Athanase Innovation AB Statistics
Total Valuation
Athanase Innovation AB has a market cap or net worth of SEK 467.08 million. The enterprise value is 40.89 million.
| Market Cap | 467.08M |
| Enterprise Value | 40.89M |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
| Earnings Date | Feb 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Athanase Innovation AB has 23.12 million shares outstanding. The number of shares has decreased by -17.96% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 23.12M |
| Shares Change (YoY) | -17.96% |
| Shares Change (QoQ) | -2.75% |
| Owned by Insiders (%) | 10.54% |
| Owned by Institutions (%) | 9.72% |
| Float | 6.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.72 |
| PB Ratio | 0.81 |
| P/TBV Ratio | 0.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.27 |
| EV / Sales | 0.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.98 |
Financial Position
The company has a current ratio of 5.71
| Current Ratio | 5.71 |
| Quick Ratio | 5.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -5.04% and return on invested capital (ROIC) is -4.27%.
| Return on Equity (ROE) | -5.04% |
| Return on Assets (ROA) | -3.82% |
| Return on Capital (ROIC) | -4.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.19 |
| Inventory Turnover | 2.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.96% in the last 52 weeks. The beta is 0.96, so Athanase Innovation AB's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | +20.96% |
| 50-Day Moving Average | 22.09 |
| 200-Day Moving Average | 18.77 |
| Relative Strength Index (RSI) | 25.05 |
| Average Volume (20 Days) | 233 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Athanase Innovation AB had revenue of SEK 136.73 million and -32.32 million in losses. Loss per share was -1.28.
| Revenue | 136.73M |
| Gross Profit | 51.12M |
| Operating Income | -43.92M |
| Pretax Income | -43.22M |
| Net Income | -32.32M |
| EBITDA | -30.27M |
| EBIT | -43.92M |
| Loss Per Share | -1.28 |
Balance Sheet
| Cash & Cash Equivalents | 426.20M |
| Total Debt | n/a |
| Net Cash | 426.20M |
| Net Cash Per Share | 18.43 |
| Equity (Book Value) | 588.34M |
| Book Value Per Share | 24.88 |
| Working Capital | 395.93M |
Cash Flow
In the last 12 months, operating cash flow was -41.74 million and capital expenditures -178,000, giving a free cash flow of -41.92 million.
| Operating Cash Flow | -41.74M |
| Capital Expenditures | -178,000 |
| Free Cash Flow | -41.92M |
| FCF Per Share | -1.81 |
Margins
Gross margin is 37.39%, with operating and profit margins of -32.12% and -23.64%.
| Gross Margin | 37.39% |
| Operating Margin | -32.12% |
| Pretax Margin | -31.61% |
| Profit Margin | -23.64% |
| EBITDA Margin | -22.14% |
| EBIT Margin | -32.12% |
| FCF Margin | n/a |
Dividends & Yields
Athanase Innovation AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 17.96% |
| Shareholder Yield | 17.96% |
| Earnings Yield | -6.36% |
| FCF Yield | -8.97% |
Stock Splits
The last stock split was on June 10, 2022. It was a reverse split with a ratio of 0.0625.
| Last Split Date | Jun 10, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0625 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |